Search Results - "glucagon"

Exploitation of Olive (<i>Olea europaea</i> L.) Seed Proteins as Upgraded Source of Bioactive Peptides with Multifunctional Properties: Focus on Antioxidant and Dipeptidyl-Dipeptidase-IV Inhibitory Activities, and Glucagon-like Peptide 1 Improved Modulation by Martina Bartolomei, Anna Laura Capriotti, Yuchen Li, Carlotta Bollati, Jianqiang Li, Andrea Cerrato, Lorenzo Cecchi, Raffaele Pugliese, Maria Bellumori, Nadia Mulinacci, Aldo Laganà, Anna Arnoldi, Carmen Lammi

Connect to this object online.

Diabetes and Heart Failure: Pathogenesis and Novel Therapeutic Approaches

Subjects: “…GLP-1 - glucagon-like peptide-1…”
DOAB: download the publication
DOAB: description of the publication

Does Therapy with Glucagon-like Peptide 1 Receptor Agonists Have an Effect on Biochemical Markers of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)?... by Marcin Hachuła, Michał Kosowski, Marcin Basiak, Bogusław Okopień

Connect to this object online.

Corrigendum to "Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: effects on weight loss and safety in adults with overweight or obesity" [Mol Metab 78 (2023) 101801] by Martin Haljeta Friedrichsen, Lars Endahl, Frederik Flindt Kreiner, Ronald Goldwater, Martin Kankam, Søren Toubro, Sune Boris Nygård

Connect to this object online.

Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries by Brandon B. Boland, Rhianna C. Laker, Siobhan O'Brien, Sadichha Sitaula, Isabelle Sermadiras, Jens Christian Nielsen, Pernille Barkholt, Urmas Roostalu, Jacob Hecksher-Sørensen, Sara Rubek Sejthen, Ditte Dencker Thorbek, Arthur Suckow, Nicole Burmeister, Stephanie Oldham, Sarah Will, Victor G. Howard, Benji M. Gill, Philip Newton, Jacqueline Naylor, David C. Hornigold, Jotham Austin, Louise Lantier, Owen P. McGuinness, James L. Trevaskis, Joseph S. Grimsby, Christopher J. Rhodes

Connect to this object online.

(E)-7-Ethylidene-lithocholic Acid (7-ELCA) Is a Potent Dual Farnesoid X Receptor (FXR) Antagonist and GPBAR1 Agonist Inhibiting FXR-Induced Gene Expression in Hepatocytes and Stimulating Glucagon-like Peptide-1 Secretion From Enteroendocrine Cells by Alzbeta Stefela, Miroslav Kaspar, Miroslav Kaspar, Martin Drastik, Thales Kronenberger, Thales Kronenberger, Stanislav Micuda, Martin Dracinsky, Blanka Klepetarova, Eva Kudova, Petr Pavek

Connect to this object online.

Comparative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor and 4 glucagon-like peptide-1 (GLP-1) receptor agonist drugs in non-alcoholic fatty liver disease: A GRADE-assessed systematic review and network meta-analysis of randomized controlled trials by Yunpeng Gu, Lei Sun, Wei Zhang, Tingting Kong, Run Zhou, Yining He, Chaohua Deng, Luping Yang, Jianing Kong, Yutong Chen, Junping Shi, Yanli Hu

Connect to this object online.

Risk of Fracture With Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, or Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis Combining 177 Randomized Controlled Trials With a Median Follow-Up of 26 weeks by Sanbao Chai, Fengqi Liu, Zhirong Yang, Shuqing Yu, Zuoxiang Liu, Qingqing Yang, Feng Sun

Connect to this object online.

Emerging Paradigms in Insulin Resistance

Subjects: “…glucagon…”
DOAB: download the publication
DOAB: description of the publication

Bioactive Molecules with Healthy Features to Food and Non-food Applications

Subjects: “…glucagon-like peptide 1…”
DOAB: download the publication
DOAB: description of the publication

Novel Molecules in Diabetes Melitus, Dyslipidemia and Cardiovascular Disease

Subjects: “…glucagon…”
DOAB: download the publication
DOAB: description of the publication

Albumin-Based Drug Delivery Systems

Subjects: “…glucagon-like peptide-1…”
DOAB: download the publication
DOAB: description of the publication

Pathological Mechanisms in Diabetes

Subjects: “…Glucagon-Like Peptide-1 Receptor…”
DOAB: download the publication
DOAB: description of the publication

Effect of Phenolic Compounds on Human Health

Subjects: “…glucagon/insulin…”
DOAB: download the publication
DOAB: description of the publication

Beta-Glucan in Foods and Health Benefits

Subjects: “…glucagon-like peptide 1 (GLP-1)…”
DOAB: download the publication
DOAB: description of the publication

Clinical Research on Diabetic Complications

Subjects: “…glucagon-like peptide-1 receptor agonists…”
DOAB: download the publication
DOAB: description of the publication

Clinical Research on Type 2 Diabetes and Its Complications

Subjects: “…glucagon-like peptide-1 receptor agonist…”
DOAB: download the publication
DOAB: description of the publication

Impaired Mitochondrial Bioenergetics under Pathological Conditions

Subjects: “…glucagon…”
DOAB: download the publication
DOAB: description of the publication

Nutritional Support for Chronic Disease

Subjects: “…Glucagon-like peptide1(GLP1)…”
DOAB: download the publication
DOAB: description of the publication

Pathogenesis of Pregnancy-Related Complication

Subjects: “…glucagon…”
DOAB: download the publication
DOAB: description of the publication